RE:RE:RE:Looked at Q3 filing on Sedar again N0taP00p ... Here's some fresh input and perspectives so you want to sound more credible and look more educated instead like posing like an uninformed in your next armchair quarterback posts.
Q1 biotech layoffs rise 87% YOY, already halfway to 2022 total
In the first quarter of 2023, 56 biopharmas laid off staff—an 87% jump over the same period in 2022, when 30 companies made cuts.
Not an obvious environment for anybody but we should get there, with high distinction of our efficacy %s keep climbing. And it won't be because of you.
You clearly don't have the attitude to face challenges. Whining seems to be your best "strength", part of your DNA. That's sad!